• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高压或特定 d-对映异构体肽抑制淀粉样 Aβ 聚集。

Inhibition of amyloid Aβ aggregation by high pressures or specific d-enantiomeric peptides.

机构信息

Physics Institute of São Carlos, University of São Paulo, São Carlos, SP, Brazil.

出版信息

Chem Commun (Camb). 2018 Mar 27;54(26):3294-3297. doi: 10.1039/c8cc01458b.

DOI:10.1039/c8cc01458b
PMID:29537428
Abstract

Pressure can shift the polymer-monomer equilibrium of Aβ, increasing pressure first leads to a release of Aβ-monomers, surprisingly at pressures higher than 180 MPa repolymerization is induced. By high pressure NMR spectroscopy, differences of partial molar volumes ΔV0 and compressibility factors Δβ' of polymerization were determined at different temperatures. The d-enantiomeric peptides RD2 and RD2D3 bind to monomeric Aβ with affinities substantially higher than those determined for fibril formation. By reducing the Aβ concentration below the critical concentration for polymerization they inhibit the formation of toxic oligomers. Chemical shift perturbation allows the identification of the binding sites. The d-peptides are candidates for drugs preventing Alzheimer's disease. We show that RD2D3 has a positive effect on the cognitive behaviour of transgenic (APPSwDI) mice prone to Alzheimer's disease. The heterodimer complexes have a smaller Stokes radius than Aβ alone indicating the recognition of a more compact conformation of Aβ identified by high pressure NMR before.

摘要

压力可以改变 Aβ 的聚合物单体平衡,增加压力首先会导致 Aβ-单体释放,但令人惊讶的是,在高于 180 MPa 的压力下会引发聚合反应。通过高压 NMR 光谱法,在不同温度下测定了聚合的偏摩尔体积差 ΔV0 和压缩系数差 Δβ'。D-对映体肽 RD2 和 RD2D3 与单体 Aβ 的结合亲和力明显高于测定的纤维形成亲和力。通过将 Aβ 浓度降低到聚合的临界浓度以下,它们可以抑制有毒寡聚物的形成。化学位移扰动允许鉴定结合位点。D-肽是预防阿尔茨海默病的药物候选物。我们表明,RD2D3 对易患阿尔茨海默病的转基因(APPSwDI)小鼠的认知行为有积极影响。杂二聚体复合物的 Stokes 半径比单独的 Aβ 小,这表明通过高压 NMR 之前鉴定的 Aβ 更紧凑构象的识别。

相似文献

1
Inhibition of amyloid Aβ aggregation by high pressures or specific d-enantiomeric peptides.高压或特定 d-对映异构体肽抑制淀粉样 Aβ 聚集。
Chem Commun (Camb). 2018 Mar 27;54(26):3294-3297. doi: 10.1039/c8cc01458b.
2
A d-enantiomeric peptide interferes with heteroassociation of amyloid-β oligomers and prion protein.一种 d-对映异构体肽干扰淀粉样β寡聚物和朊病毒蛋白的异源聚合。
J Biol Chem. 2018 Oct 12;293(41):15748-15764. doi: 10.1074/jbc.RA118.003116. Epub 2018 Aug 21.
3
Aβ Oligomer Elimination Restores Cognition in Transgenic Alzheimer's Mice with Full-blown Pathology.Aβ 寡聚物清除可恢复完全发病的转基因阿尔茨海默病小鼠的认知功能。
Mol Neurobiol. 2019 Mar;56(3):2211-2223. doi: 10.1007/s12035-018-1209-3. Epub 2018 Jul 12.
4
Deceleration of the neurodegenerative phenotype in pyroglutamate-Aβ accumulating transgenic mice by oral treatment with the Aβ oligomer eliminating compound RD2.通过口服给予 Aβ 寡聚物清除化合物 RD2 可减缓焦谷氨酸-Aβ 蓄积转基因小鼠的神经退行性表型。
Neurobiol Dis. 2019 Apr;124:36-45. doi: 10.1016/j.nbd.2018.10.021. Epub 2018 Nov 2.
5
Interaction of Therapeutic d-Peptides with Aβ42 Monomers, Thermodynamics, and Binding Analysis.治疗性 d-Peptides 与 Aβ42 单体的相互作用:热力学和结合分析。
ACS Chem Neurosci. 2022 Jun 1;13(11):1638-1650. doi: 10.1021/acschemneuro.2c00102. Epub 2022 May 17.
6
The ongoing search for small molecules to study metal-associated amyloid-β species in Alzheimer's disease.正在寻找小分子以研究阿尔茨海默病中与金属相关的淀粉样-β 物种。
Acc Chem Res. 2014 Aug 19;47(8):2475-82. doi: 10.1021/ar500152x. Epub 2014 Jul 31.
7
Increase of Positive Net Charge and Conformational Rigidity Enhances the Efficacy of d-Enantiomeric Peptides Designed to Eliminate Cytotoxic Aβ Species.增加正净电荷和构象刚性可提高设计用于消除细胞毒性 Aβ 物种的 d-对映体肽的功效。
ACS Chem Neurosci. 2016 Aug 17;7(8):1088-96. doi: 10.1021/acschemneuro.6b00047. Epub 2016 Jun 9.
8
Development of retro-inverso peptides as anti-aggregation drugs for β-amyloid in Alzheimer's disease.反义肽作为阿尔茨海默病β-淀粉样蛋白聚集抑制剂的研发。
Peptides. 2010 Oct;31(10):1866-72. doi: 10.1016/j.peptides.2010.06.033. Epub 2010 Jul 13.
9
Specific binding of a β-cyclodextrin dimer to the amyloid β peptide modulates the peptide aggregation process.β-环糊精二聚体与淀粉样β肽的特异性结合调节肽的聚集过程。
Biochemistry. 2012 May 29;51(21):4280-9. doi: 10.1021/bi300341j. Epub 2012 May 17.
10
Low-n oligomers as therapeutic targets of Alzheimer's disease.低聚物作为阿尔茨海默病的治疗靶点。
J Neurochem. 2011 Apr;117(1):19-28. doi: 10.1111/j.1471-4159.2011.07187.x. Epub 2011 Feb 9.

引用本文的文献

1
In Vitro and In Vivo Efficacies of the Linear and the Cyclic Version of an All-d-Enantiomeric Peptide Developed for the Treatment of Alzheimer's Disease.用于治疗老年痴呆症的全 d-对映体肽的线性和环状版本的体外和体内功效。
Int J Mol Sci. 2021 Jun 18;22(12):6553. doi: 10.3390/ijms22126553.
2
Observation of β-Amyloid Peptide Oligomerization by Pressure-Jump NMR Spectroscopy.利用压力跳跃 NMR 光谱法观察 β-淀粉样肽寡聚体的形成。
J Am Chem Soc. 2019 Sep 4;141(35):13762-13766. doi: 10.1021/jacs.9b06970. Epub 2019 Aug 23.
3
Importance of time-ordered non-uniform sampling of multi-dimensional NMR spectra of Aβ peptide under aggregating conditions.
在聚集条件下 Aβ 肽的多维 NMR 谱的时间有序非均匀采样的重要性。
J Biomol NMR. 2019 Sep;73(8-9):429-441. doi: 10.1007/s10858-019-00235-7. Epub 2019 Aug 12.
4
A d-enantiomeric peptide interferes with heteroassociation of amyloid-β oligomers and prion protein.一种 d-对映异构体肽干扰淀粉样β寡聚物和朊病毒蛋白的异源聚合。
J Biol Chem. 2018 Oct 12;293(41):15748-15764. doi: 10.1074/jbc.RA118.003116. Epub 2018 Aug 21.
5
Aβ Oligomer Elimination Restores Cognition in Transgenic Alzheimer's Mice with Full-blown Pathology.Aβ 寡聚物清除可恢复完全发病的转基因阿尔茨海默病小鼠的认知功能。
Mol Neurobiol. 2019 Mar;56(3):2211-2223. doi: 10.1007/s12035-018-1209-3. Epub 2018 Jul 12.